Galectin Therapeutics Inc. (GALT)

NCM – Real Time Price. Currency in USD

3.17

+0.04 (1.28%)

Market open: Aug 12, 2026, 3:47 PM EDT

3.13

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-53K

-37K

-33K

-32K

Gross Profit

-53K

-37K

-33K

-32K

Operating expenses (excl. COGS)

-20M

-42M

-38M

Operating Income

-20M

-42M

-38M

Non-operating income, total

-11M

-5M

-3M

-424K

Pretax income

-31M

-47M

-41M

-39M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-31M

-47M

-41M

-39M

Discontinued operations

Net income

-31M

-47M

-41M

-39M

Dilution adjustment

-4M

Preferred dividends

138K

153K

120K

97K

Galectin Therapeutics Inc. (GALT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Galectin Therapeutics Inc. (GALT)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Galectin Therapeutics Inc. (GALT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Galectin Therapeutics Inc. (GALT)

Income Statement (Annual)

Income Statement (Annual)